Exciting News!
As a founding member of the newly launched Association of Multisite Research Corporations (AMRC), CenExel is proud to join forces with 13 other leading multisite organizations to revolutionize clinical research. Together, AMRC represents a powerful network of more than 400 sites, nearly 1,000 Principal Investigators (PIs), and over 7,000 research professionals. In 2024 alone, AMRC members collectively enrolled over 73,500 patients into clinical trials, showcasing the strength and scalability of multisite networks.
Reduce the delays that affect nearly 80% of clinical trials.
Streamline processes to address rising complexity in studies, with clinical trial numbers growing 19% between 2012 and 2022.
Promote collaboration, consistency, and data quality to accelerate drug development and improve patient outcomes.
Our Commitment to Ethical Clinical Research
Aligned with AMRC principles to ensure quality, safety, and transparency
About AMRC
The Association of Medical Research Companies (AMRC) promotes excellence in clinical research by ensuring ethical practices, regulatory compliance, and patient-focused methodologies.
Our Commitment
- Ethical research practices
- Patient safety & privacy protection
- Regulatory compliance
- Transparent clinical trials
- Continuous staff training
Why It Matters
Following AMRC standards ensures responsible research conduct, strengthens trust, and guarantees high-quality clinical outcomes for patients and partners.
Core Values
- Patient-First Approach
- Data Integrity
- Regulatory Excellence
- Innovation in Research